Ursprung des Netzwerks ersten Grades von Gerrit Los
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gerrit Los
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PRESIDIO PROPERTY TRUST, INC. | Real Estate Investment Trusts | Comptroller/Controller/Auditor | |
| CEPHEID | Medical Specialties | Director/Board Member | |
| HTG MOLECULAR DIAGNOSTICS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| IRHYTHM TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member | |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Patara Pharma LLC provides biotechnology solutions. It develops biopharmaceutical therapy for the treatment of allergic and inflammatory diseases and conditions that affect orphan patient populations. The company was founded by William Gerhart, Pravin Soni and Ahmet Tutuncu in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| COTY INC. | Household/Personal Care | Comptroller/Controller/Auditor | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Hofstra University | College/University | Masters Business Admin | |
| University of California, Irvine | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| University of Uppsala | College/University | Doctorate Degree | |
| University of San Diego | College/University | Masters Business Admin Undergraduate Degree | |
Norwest Venture Partners
 Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners is a venture capital division of Norwest Partners founded in 1961. The firm is headquartered in Palo Alto, California with additional offices in Mumbai and Herzliya. | Investment Managers | Private Equity Investor | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NEVRO CORP. | Medical Specialties | Director/Board Member | |
Cianna Medical, Inc.
 Cianna Medical, Inc. Medical SpecialtiesHealth Technology Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA. | Medical Specialties | Director/Board Member | |
| East China University of Science & Technology | College/University | Undergraduate Degree | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OTONOMY | Biotechnology | Director/Board Member | |
| Astellas Pharmaceuticals SA | Corporate Officer/Principal | ||
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor | |
| ADAGENE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Speak, Inc.
 Speak, Inc. Miscellaneous Commercial ServicesCommercial Services Speak, Inc. operates as a speaker bureau. | Miscellaneous Commercial Services | Chairman | |
MDLIVE, Inc.
 MDLIVE, Inc. Packaged SoftwareTechnology Services MDLIVE, Inc. operates as a telehealth provider of online and on-demand healthcare delivery services and software. Its cloud-based virtual medical office software platform enables patients, medical professionals, and plan administrators to collaborate through voice, video, email, and mobile devices; and allows payers and providers to collect and share clinical data from patient medical records, lab results, and in-home biometric devices for real-time risk assessments, wellness advice, diagnosis, and treatment. The company was founded by Randy Parker and Steven Victor Gurland in 2009 and is headquartered in Sunrise, FL. | Packaged Software | Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ARCELLX, INC. | Biotechnology | Director/Board Member | |
Forge Therapeutics, Inc.
 Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| NKARTA, INC. | Biotechnology | Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Pharmaceuticals: Major | Director/Board Member | |
Allievex Corp.
 Allievex Corp. Pharmaceuticals: OtherHealth Technology Allievex Corp. operates as a biotechnology company. It develops therapies for the treatment of rare pediatric neurodegenerative diseases. The company was founded by Thomas P. Mathers and Eric H. Zanelli and is headquartered in Marblehead, MA. | Pharmaceuticals: Other | Director/Board Member | |
| San Diego Food System Alliance | Director/Board Member | ||
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 45 |
| China | 3 |
| Schweden | 2 |
| Belgien | 2 |
| Griechenland | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 8 |
| Finance | 7 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 65 |
| Independent Dir/Board Member | 31 |
| Corporate Officer/Principal | 22 |
| Director of Finance/CFO | 19 |
| Undergraduate Degree | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Schmid | 24 |
| Tiba Aynechi | 24 |
| Robert Hoffman | 22 |
| Hollings Renton | 17 |
| James Schoeneck | 12 |
| David John King | 10 |
| Matthew Moyle | 9 |
| Dominic Piscitelli | 7 |
| Qing Hai Zhao | 7 |
| Jessica C. Joelson | 6 |
| Steven Turkowiak | 4 |
| David McKeon | 3 |
| Jamie A. Tereschuck | 3 |
- Börse
- Insiders
- Gerrit Los
- Unternehmensverbindungen
